Rituximab
treatment
3 mentions
3 recordings
first heard Dec 2025
last heard 14 Aug
↑1 vs the 6 months before
Monoclonal antibody used in B-cell lymphomas that can reduce risk of transformation to aggressive disease.
Trend
Peak in the week of 14 Aug — 1 mentions across 1 series.
Moments
newest first · ▶ plays the momentMark McClureTalking Rheumatology Spotlight · Ep 55: A spotlight on vasculitis and the kidneys · 8:38 · 14 Aug
…And, you know, as as as as you know, it compared rituximab and and um and cycrophosphamide head to head in patients with with severe AAV.…
Dr. Robbie John (Robbie) - HostThe Clinical Problem Solvers · Episode 464 – Special Episode – A Case from the RLR Boo... · 22:23 · 6 Jul
…Rituximab could reduce the already low lifetime risk of transformation into an aggressive lymphoma, but there was certainly time to think.…
Prof. Dr. Philipp AlbrechtUnter 4 Augen - der Wissenschaftspodcast der Ophthalmologie · Neuromyelitis-optica-Spektrum & MOG-Erkrankungen · 12:38 · 20 Dec
…Off-Label haben wir sehr, sehr lange Rituximab eingesetzt mit sehr gutem Erfolg.…
All 3 moments